Comprehensive comparison of global coagulation assays to differentiate lupus anticoagulant from acquired hemophilia A in patients with prolonged APTT

被引:1
作者
Chikasawa, Yushi [1 ]
Amano, Kagehiro [1 ]
Shinozawa, Keiko [1 ]
Bingo, Masato [1 ]
Miyashita, Ryui [1 ]
Yamaguchi, Tomoko [1 ]
Mitsuhashi, Ayano [2 ]
Inaba, Hiroshi [1 ]
Hagiwara, Takeshi [1 ]
Kinai, Ei [1 ]
机构
[1] Tokyo Med Univ, Dept Lab Med, 6-7-1 Nishishinjuku,Shinjuku Ku, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Gene Res Coagulat Disorders, Tokyo, Japan
关键词
Lupus anticoagulant; Acquired hemophilia; NATEM mode in ROTEM; Thrombin generation assay; Clot waveform analysis; ROTATIONAL THROMBOELASTOMETRY ASSAY; FACTOR-VIII ANTIBODIES; THROMBIN GENERATION; STANDARDIZATION COMMITTEE; INTERNATIONAL-SOCIETY; MIXING TEST; GUIDELINES; MANAGEMENT; DIAGNOSIS; REVEALS;
D O I
10.1007/s12185-023-03659-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is no established method for differentiating acquired hemophilia A (AHA) from lupus anticoagulant (LA) positivity because both present with prolonged activated partial thromboplastin time. We compared various parameters of rotational thromboelastometry (ROTEM), thrombin generation assay (TGA), and clot waveform analysis (CWA) in patients with AHA (n = 10) and LA (n = 44). Compared with AHA, possible (n = 12) and definite (n = 32) LA showed significantly shorter clotting time (CT) in NATEM mode of ROTEM (> 3600 vs. 501/533). In TGA, peak height was significantly lower in AHA (16 vs. 242/174 nM). In CWA, CT was significantly longer (81 vs. 36/41 s) and Ad|min1| was lower (2.1 vs. 8.7/6.7) in AHA. Notably, CT by NATEM and peak height in TGA completely discriminated between AHA and LA, whereas Ad|min1| did not discriminate between them in 4 cases of AHA and 1 of LA. Comparison of 3 patients with both AHA and LA against a patient with only LA and markedly low FVIII activity (3.5%) showed that both CT by NATEM and peak height of TGA precisely classified the former 3 cases as AHA and the latter 1 case as LA, whereas Ad|min1| classified all 4 cases as AHA. ROTEM and TGA can comparably distinguish between AHA and LA.
引用
收藏
页码:577 / 588
页数:12
相关论文
共 51 条
[1]   NATURAL ANTIBODIES TO FACTOR-VIII (ANTI-HEMOPHILIC FACTOR) IN HEALTHY-INDIVIDUALS [J].
ALGIMAN, M ;
DIETRICH, G ;
NYDEGGER, UE ;
BOIELDIEU, D ;
SULTAN, Y ;
KAZATCHKINE, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3795-3799
[2]   Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A [J].
Batty, Paul ;
Moore, Gary W. ;
Platton, Sean ;
Maloney, James C. ;
Palmer, Ben ;
Bowles, Louise ;
Pasi, K. John ;
Rangarajan, Savita ;
Hart, Daniel P. .
THROMBOSIS AND HAEMOSTASIS, 2015, 114 (04) :804-811
[3]  
Blanco AN, 2002, HAEMATOLOGICA, V87, P271
[4]   Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors [J].
Bonnefoy, Arnaud ;
Merlen, Clemence ;
Dube, Evemie ;
Claus-Desbonnet, Hadrien ;
Rivard, Georges-Etienne ;
St-Louis, Jean .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (12) :2947-2956
[5]   Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor [J].
Brings, HA ;
Waas, JK ;
McCrae, KR ;
Baele, HR ;
Goldstone, J .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (04) :853-+
[6]   Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up [J].
Chansavang, Albain ;
Philippe, Aurelien ;
Bozinovic, Ines ;
Ali, Khalil Ben Hadj ;
Smadja, David ;
Helley, Dominique ;
Darnige, Luc ;
Mauge, Laetitia .
ANNALS OF HEMATOLOGY, 2022, 101 (11) :2453-2460
[7]   Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO [J].
Collins, Peter W. ;
Chalmers, Elizabeth ;
Hart, Daniel ;
Jennings, Ian ;
Liesner, Ri ;
Rangarajan, Savita ;
Talks, Kate ;
Williams, Michael ;
Hay, Charles R. M. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (06) :758-773
[8]   ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease [J].
Connell, Nathan T. ;
Flood, Veronica H. ;
Brignardello-Petersen, Romina ;
Abdul-Kadir, Rezan ;
Arapshian, Alice ;
Couper, Susie ;
Grow, Jean M. ;
Kouides, Peter ;
Laffan, Michael ;
Lavin, Michelle ;
Leebeek, Frank W. G. ;
O'Brien, Sarah H. ;
Ozelo, Margareth C. ;
Tosetto, Alberto ;
Weyand, Angela C. ;
James, Paula D. ;
Kalot, Mohamad A. ;
Husainat, Nedaa ;
Mustafa, Reem A. .
BLOOD ADVANCES, 2021, 5 (01) :301-325
[9]   Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine [J].
Depasse, Francois ;
Binder, Nikolaus B. ;
Mueller, Julia ;
Wissel, Thomas ;
Schwers, Stephan ;
Germer, Matthias ;
Hermes, Bjorn ;
Turecek, Peter L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (12) :2907-2917
[10]   Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection and interpretation [J].
Devreese, Katrien M. J. ;
de Groot, Philip G. ;
de Laat, Bas ;
Erkan, Doruk ;
Favaloro, Emmanuel J. ;
Mackie, Ian ;
Martinuzzo, Marta ;
Ortel, Thomas L. ;
Pengo, Vittorio ;
Rand, Jacob H. ;
Tripodi, Armando ;
Wahl, Denis ;
Cohen, Hannah .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (11) :2828-2839